Heister et al., 2013 - Google Patents
Are carbon nanotubes a natural solution? Applications in biology and medicineHeister et al., 2013
- Document ID
- 13759762297765442081
- Author
- Heister E
- Brunner E
- Dieckmann G
- Jurewicz I
- Dalton A
- Publication year
- Publication venue
- ACS applied materials & interfaces
External Links
Snippet
Carbon nanotubes and materials based on carbon nanotubes have many perceived applications in the field of biomedicine. Several highly promising examples have been highlighted in the literature, ranging from their use as growth substrates or tissue scaffolds to …
- 239000002041 carbon nanotube 0 title abstract description 426
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48776—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form forms of ingredients not provided for by groups A61K47/48784 - A61K47/48992, e.g. cells, cell fragments, viruses, ghosts, red blood cells, viral vectors having the pharmacologically or therapeutically active agent complexed or covalently linked to, or being themselves modified by complexation or covalent linkage by a modifying agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Heister et al. | Are carbon nanotubes a natural solution? Applications in biology and medicine | |
Kumar et al. | Carbon nanotubes: a novel material for multifaceted applications in human healthcare | |
Gholami et al. | 3D nanostructures for tissue engineering, cancer therapy, and gene delivery | |
Kumar et al. | Advances in nanotechnology and nanomaterials based strategies for neural tissue engineering | |
Alagarsamy et al. | Carbon nanomaterials for cardiovascular theranostics: Promises and challenges | |
Ghosal et al. | Biomedical applications of graphene nanomaterials and beyond | |
Hasan et al. | Nanoparticles in tissue engineering: applications, challenges and prospects | |
Verma et al. | Nanomaterials for regenerative medicine | |
Serpell et al. | Can carbon nanotubes deliver on their promise in biology? Harnessing unique properties for unparalleled applications | |
Bottini et al. | PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead | |
Gilmore et al. | Novel nanomaterials for clinical neuroscience | |
Krishna et al. | Graphene-based nanomaterials for nanobiotechnology and biomedical applications | |
Li et al. | Current investigations into carbon nanotubes for biomedical application | |
Malarkey et al. | Conductive single-walled carbon nanotube substrates modulate neuronal growth | |
Perán et al. | Functionalized nanostructures with application in regenerative medicine | |
Zhou et al. | Application of graphene/graphene oxide in biomedicine and biotechnology | |
Yi et al. | Recent progress in nanotechnology for stem cell differentiation, labeling, tracking and therapy | |
Wang et al. | Carbon nanotubes in biology and medicine: An overview | |
Lakshmanan et al. | Graphene-based drug delivery systems in tissue engineering and nanomedicine | |
Bressan et al. | Nanotechnology to drive stem cell commitment | |
Mostafavi et al. | Carbon-based nanomaterials in gene therapy | |
Hui et al. | Graphene family nanomaterials for stem cell neurogenic differentiation and peripheral nerve regeneration | |
Keshavarz et al. | Cell selective apoptosis induced by polymorphic alteration of self-assembled silica nanowebs | |
Shariati et al. | Nanobased platform advances in cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering | |
Huang et al. | 3D gradient and linearly aligned magnetic microcapsules in nerve guidance conduits with remotely spatiotemporally controlled release to enhance peripheral nerve repair |